Although a recent controversy with competitor MRNA might lift NVAX stock in the near term, it’s not something to depend on. More
Articles
SoFi Stock Could Bounce Back, But It’s Not Worth the Risk
Putting it simply, going long SOFI stock in the hopes it bounces back to $17 per share, may not be worth it, if there's a decent risk of market volatility sending it below $10 per share. Wait for uncertainty before buying. More
Rocket Companies May Be One of the Last True Value Stocks Out There
RKT stock deserves more respect from investors. With its low valuation and strong fundamentals, this rare bargain may not last long. More
Uber Stock Looks Dicey as Labor Problems Persist
Uber is buying more freight and delivery services as it fights for a profit against a rising revolt of drivers. More
Senseonic Stock Is Climbing After Bouncing Back From a Disappointing Q2
Despite a mixed Q2 2021 result, bullish sentiment is building for Senseonics. Here’s why SENS stock can run-up in the future. More
Carnival Stands a Disaster Away From Losing Everything
Although society generally did everything right, the worsening pandemic likely confirms that CCL stock is far from out of the woods. More
For Long-Term Investors, the Odds Favor fuboTV Stock
FUBO stock holds potential as a cable replacement, as a sports gambling palace, or as a buyout target by a larger streaming outfit. More
